Some studies showed that PIK3CA mutation was associated with shorter PFS and/or OS.24, 41 Ogino et al suggested that PIK3CA mutations were a poor prognostic factor in stage I‐III CRC patients.42 However, we did not find PIK3CA mutation associated with poor outcome. Here, PIK3CA is linked to colorectal carcinoma.